ERBB2 and breast carcinoma: To evaluate the effect of AZD1152-HQPA on breast cancer cells, HER18 (ER+, PR+, p53wt) breast cancer cells, which stably overexpress HER2 (parent line, MCF-7) [19], were treated with AZD1152-HQPA.